TRIDENT LIFELINE
|
TRIDENT LIFELINE Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| INCOME : | ||||
| Gross Sales | ₹87 Cr | ₹45 Cr | ₹32 Cr | ₹22 Cr |
| Sales | ₹83 Cr | ₹42 Cr | ₹31 Cr | ₹22 Cr |
| Job Work/ Contract Receipts | - | - | - | - |
| Processing Charges / Service Income | ₹4.27 Cr | ₹3.06 Cr | ₹0.28 Cr | - |
| Revenue from property development | - | - | - | - |
| Other Operational Income | - | - | - | - |
| Less: Excise Duty | - | - | - | - |
| Net Sales | ₹87 Cr | ₹45 Cr | ₹32 Cr | ₹22 Cr |
| EXPENDITURE : | ||||
| Increase/Decrease in Stock | ₹0.71 Cr | ₹-1.23 Cr | ₹-2.90 Cr | ₹-0.46 Cr |
| Raw Material Consumed | ₹36 Cr | ₹26 Cr | ₹19 Cr | ₹11 Cr |
| Opening Raw Materials | ₹8.47 Cr | ₹2.40 Cr | ₹1.84 Cr | ₹3.38 Cr |
| Purchases Raw Materials | ₹43 Cr | ₹19 Cr | ₹8.93 Cr | ₹5.09 Cr |
| Closing Raw Materials | ₹17 Cr | ₹5.02 Cr | ₹2.40 Cr | ₹1.84 Cr |
| Other Direct Purchases / Brought in cost | ₹1.80 Cr | ₹9.46 Cr | ₹11 Cr | ₹4.60 Cr |
| Other raw material cost | - | - | - | - |
| Power & Fuel Cost | ₹1.36 Cr | ₹0.26 Cr | ₹0.10 Cr | ₹0.02 Cr |
| Electricity & Power | ₹1.26 Cr | ₹0.24 Cr | ₹0.08 Cr | ₹0.02 Cr |
| Oil, Fuel & Natural gas | ₹0.10 Cr | ₹0.02 Cr | ₹0.02 Cr | - |
| Coals etc | - | - | - | - |
| Other power & fuel | - | - | - | - |
| Employee Cost | ₹11 Cr | ₹1.93 Cr | ₹1.39 Cr | ₹1.10 Cr |
| Salaries, Wages & Bonus | ₹11 Cr | ₹2.16 Cr | ₹1.36 Cr | ₹1.02 Cr |
| Contributions to EPF & Pension Funds | ₹0.17 Cr | ₹0.07 Cr | ₹0.05 Cr | ₹0.06 Cr |
| Workmen and Staff Welfare Expenses | ₹0.16 Cr | ₹0.07 Cr | ₹0.04 Cr | ₹0.02 Cr |
| Other Employees Cost | ₹-0.21 Cr | ₹-0.37 Cr | ₹-0.06 Cr | - |
| Other Manufacturing Expenses | ₹11 Cr | ₹6.26 Cr | ₹4.64 Cr | ₹4.63 Cr |
| Sub-contracted / Out sourced services | - | - | - | - |
| Processing Charges | ₹1.19 Cr | ₹1.31 Cr | ₹0.74 Cr | ₹1.10 Cr |
| Repairs and Maintenance | - | - | - | - |
| Packing Material Consumed | ₹8.81 Cr | ₹4.53 Cr | ₹3.82 Cr | ₹3.46 Cr |
| Other Mfg Exp | ₹1.13 Cr | ₹0.43 Cr | ₹0.09 Cr | ₹0.07 Cr |
| General and Administration Expenses | ₹4.93 Cr | ₹0.91 Cr | ₹0.72 Cr | ₹0.81 Cr |
| Rent , Rates & Taxes | ₹0.89 Cr | ₹0.33 Cr | ₹0.34 Cr | ₹0.14 Cr |
| Insurance | ₹0.11 Cr | ₹0.03 Cr | ₹0.01 Cr | ₹0.03 Cr |
| Printing and stationery | ₹0.18 Cr | ₹0.09 Cr | ₹0.04 Cr | ₹0.03 Cr |
| Professional and legal fees | ₹1.18 Cr | ₹0.44 Cr | ₹0.38 Cr | ₹0.13 Cr |
| Traveling and conveyance | ₹0.38 Cr | ₹0.15 Cr | ₹0.14 Cr | ₹0.32 Cr |
| Other Administration | ₹2.19 Cr | ₹-0.12 Cr | ₹-0.20 Cr | ₹0.17 Cr |
| Selling and Distribution Expenses | ₹5.76 Cr | ₹1.44 Cr | ₹1.75 Cr | ₹1.62 Cr |
| Advertisement & Sales Promotion | ₹0.44 Cr | ₹0.17 Cr | ₹0.04 Cr | ₹0.08 Cr |
| Sales Commissions & Incentives | ₹0.42 Cr | ₹0.22 Cr | ₹0.18 Cr | ₹0.07 Cr |
| Freight and Forwarding | ₹0.12 Cr | ₹0.06 Cr | ₹0.02 Cr | ₹0.01 Cr |
| Handling and Clearing Charges | ₹4.44 Cr | ₹1.00 Cr | ₹1.52 Cr | ₹1.47 Cr |
| Other Selling Expenses | ₹0.33 Cr | - | - | - |
| Miscellaneous Expenses | ₹1.35 Cr | ₹0.78 Cr | ₹0.42 Cr | ₹0.11 Cr |
| Bad debts /advances written off | ₹0.07 Cr | ₹0.02 Cr | - | - |
| Provision for doubtful debts | - | - | - | - |
| Losson disposal of fixed assets(net) | - | - | - | - |
| Losson foreign exchange fluctuations | ₹0.06 Cr | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - |
| Other Miscellaneous Expenses | ₹1.22 Cr | ₹0.76 Cr | ₹0.42 Cr | ₹0.11 Cr |
| Less: Expenses Capitalised | - | - | - | - |
| Total Expenditure | ₹72 Cr | ₹36 Cr | ₹25 Cr | ₹19 Cr |
| Operating Profit (Excl OI) | ₹15 Cr | ₹8.23 Cr | ₹6.27 Cr | ₹2.71 Cr |
| Other Income | ₹8.23 Cr | ₹2.08 Cr | ₹1.16 Cr | ₹0.60 Cr |
| Interest Received | ₹1.88 Cr | ₹1.46 Cr | ₹0.76 Cr | - |
| Dividend Received | - | - | - | - |
| Profit on sale of Fixed Assets | - | - | - | - |
| Profits on sale of Investments | - | ₹0.02 Cr | - | - |
| Provision Written Back | - | - | - | - |
| Foreign Exchange Gains | ₹0.37 Cr | ₹0.16 Cr | ₹0.21 Cr | ₹0.10 Cr |
| Others | ₹5.99 Cr | ₹0.45 Cr | ₹0.20 Cr | ₹0.51 Cr |
| Operating Profit | ₹23 Cr | ₹10 Cr | ₹7.43 Cr | ₹3.31 Cr |
| Interest | ₹4.14 Cr | ₹0.65 Cr | ₹0.48 Cr | ₹0.13 Cr |
| InterestonDebenture / Bonds | - | - | - | - |
| Interest on Term Loan | ₹1.54 Cr | ₹0.17 Cr | ₹0.22 Cr | ₹0.06 Cr |
| Intereston Fixed deposits | - | - | - | - |
| Bank Charges etc | ₹0.50 Cr | ₹0.13 Cr | ₹0.14 Cr | ₹0.06 Cr |
| Other Interest | ₹2.11 Cr | ₹0.35 Cr | ₹0.12 Cr | ₹0.00 Cr |
| PBDT | ₹19 Cr | ₹9.67 Cr | ₹6.95 Cr | ₹3.19 Cr |
| Depreciation | ₹5.49 Cr | ₹0.97 Cr | ₹0.37 Cr | ₹0.20 Cr |
| Profit Before Taxation & Exceptional Items | ₹14 Cr | ₹8.70 Cr | ₹6.58 Cr | ₹2.98 Cr |
| Exceptional Income / Expenses | - | - | - | - |
| Profit Before Tax | ₹14 Cr | ₹8.70 Cr | ₹6.58 Cr | ₹2.98 Cr |
| Provision for Tax | ₹3.12 Cr | ₹2.76 Cr | ₹0.56 Cr | ₹-0.96 Cr |
| Current Income Tax | ₹4.54 Cr | ₹2.38 Cr | ₹0.54 Cr | ₹0.50 Cr |
| Deferred Tax | ₹-1.42 Cr | ₹0.37 Cr | ₹0.52 Cr | ₹-0.82 Cr |
| Other taxes | ₹0.00 Cr | ₹0.00 Cr | ₹-0.50 Cr | ₹-0.64 Cr |
| Profit After Tax | ₹10 Cr | ₹5.94 Cr | ₹6.02 Cr | ₹3.95 Cr |
| Extra items | - | - | - | - |
| Minority Interest | ₹1.25 Cr | ₹0.40 Cr | ₹0.00 Cr | - |
| Share of Associate | - | - | - | - |
| Other Consolidated Items | - | - | - | - |
| Consolidated Net Profit | ₹12 Cr | ₹6.34 Cr | ₹6.02 Cr | ₹3.95 Cr |
| Adjustments to PAT | - | - | - | - |
| Profit Balance B/F | ₹9.37 Cr | ₹2.22 Cr | ₹-3.22 Cr | ₹-7.17 Cr |
| Appropriations | ₹21 Cr | ₹8.57 Cr | ₹2.79 Cr | ₹-3.22 Cr |
| General Reserves | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - |
| Corporate dividend tax | - | - | - | - |
| Other Appropriation | - | - | ₹0.50 Cr | - |
| Equity Dividend % | - | - | - | - |
| Earnings Per Share | ₹10.22 | ₹5.52 | ₹5.23 | ₹4.93 |
| Adjusted EPS | ₹10.22 | ₹5.52 | ₹5.23 | ₹4.93 |
Compare Income Statement of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹343.9 Cr | 0.7% | 1.4% | 6.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹409,626.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,669.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,793.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| CIPLA | ₹122,103.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,857.4 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 0.7% |
1.4% |
6.8% |
| SENSEX | -0.9% |
4.6% |
5% |
You may also like the below Video Courses